Videos
Despite concerns over a bubble and regulation, biotech investing remains very hot for investors. It doesn’t hurt that even with the recent sell-off the space is easily outperforming broad indexes so far in 2015. But with added risks, it might be time for investors to consider an ETF approach to the space so that one company doesn’t blow up a portfolio.

Eric Dutram takes a look at the biotech ETF space and some of the key differences between the most popular funds in the space in this video. He also highlights a few factors that investors must consider when they are deciding which ETF is the best for their biotech investing needs.

SPDR SP Biotech ETF: http://www.zacks.com/funds/etf/XBI/profile?cid=cs-youtube-ft-card
iShares NASDAQ Biotechnology Index Fund: http://www.zacks.com/funds/etf/IBB/profile?cid=cs-youtube-ft-card
Market Vectors Biotech ETF: http://www.zacks.com/funds/etf/BBH/profile?cid=cs-youtube-ft-card
Bioshares Biotechnology Clinical Trials: http://www.zacks.com/funds/etf/BBC/profile?cid=cs-youtube-ft-card
Bioshares Biotechnology Products Fund: http://www.zacks.com/funds/etf/BBP/profile?cid=cs-youtube-ft-card

Follow us on StockTwits: http://stocktwits.com/ZacksResearch
Follow us on Twitter: https://twitter.com/ZacksResearch
Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Articles You May Like

Top Stock Picks for the Week of Aug 13, 2018
Stocks making the biggest moves midday: Zscaler, Marvell Technology, DoorDash and more
FTX hacker reportedly transfers a portion of stolen funds to OKX after using Bitcoin mixer
Mortgage Rates Fall As Inflation Eases And Fed Signals Smaller Hikes Ahead
Coca-Cola FEMSA and Adidas AG: 11/30/2022 Bull & Bear